JP2004528529A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528529A5 JP2004528529A5 JP2002545565A JP2002545565A JP2004528529A5 JP 2004528529 A5 JP2004528529 A5 JP 2004528529A5 JP 2002545565 A JP2002545565 A JP 2002545565A JP 2002545565 A JP2002545565 A JP 2002545565A JP 2004528529 A5 JP2004528529 A5 JP 2004528529A5
- Authority
- JP
- Japan
- Prior art keywords
- igf
- binding protein
- pharmaceutical composition
- composition according
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims 12
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 12
- 102000028416 insulin-like growth factor binding Human genes 0.000 claims 11
- 108091022911 insulin-like growth factor binding Proteins 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 208000005107 Premature Birth Diseases 0.000 claims 5
- 210000004291 uterus Anatomy 0.000 claims 5
- 239000000556 agonist Substances 0.000 claims 4
- 239000005022 packaging material Substances 0.000 claims 3
- 239000008177 pharmaceutical agent Substances 0.000 claims 3
- 206010012559 Developmental delay Diseases 0.000 claims 2
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 claims 2
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 claims 2
- 206010022840 Intraventricular haemorrhage Diseases 0.000 claims 2
- 208000036626 Mental retardation Diseases 0.000 claims 2
- 206010051606 Necrotising colitis Diseases 0.000 claims 2
- 206010036595 Premature delivery Diseases 0.000 claims 2
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 2
- 206010006475 bronchopulmonary dysplasia Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 208000004995 necrotizing enterocolitis Diseases 0.000 claims 2
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 206010036590 Premature baby Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 230000002596 correlated effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004405A SE0004405D0 (sv) | 2000-11-28 | 2000-11-28 | New composition and use |
| US27425201P | 2001-03-09 | 2001-03-09 | |
| PCT/US2001/047285 WO2002043578A2 (en) | 2000-11-28 | 2001-11-13 | Determination of risk and treatment of complications of prematurity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008059153A Division JP5089443B2 (ja) | 2000-11-28 | 2008-03-10 | 未熟児合併症のリスクの決定および治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004528529A JP2004528529A (ja) | 2004-09-16 |
| JP2004528529A5 true JP2004528529A5 (https=) | 2005-12-22 |
| JP4173732B2 JP4173732B2 (ja) | 2008-10-29 |
Family
ID=26655321
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002545565A Expired - Lifetime JP4173732B2 (ja) | 2000-11-28 | 2001-11-13 | 未熟児合併症のリスクの決定および治療 |
| JP2008059153A Expired - Lifetime JP5089443B2 (ja) | 2000-11-28 | 2008-03-10 | 未熟児合併症のリスクの決定および治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008059153A Expired - Lifetime JP5089443B2 (ja) | 2000-11-28 | 2008-03-10 | 未熟児合併症のリスクの決定および治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7144707B2 (https=) |
| EP (1) | EP1402266B1 (https=) |
| JP (2) | JP4173732B2 (https=) |
| AT (1) | ATE495443T1 (https=) |
| AU (2) | AU2002239560B2 (https=) |
| CA (1) | CA2429615C (https=) |
| CY (1) | CY1111213T1 (https=) |
| DE (1) | DE60143858D1 (https=) |
| WO (1) | WO2002043578A2 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8518877B2 (en) | 2007-04-18 | 2013-08-27 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003012043A2 (en) * | 2001-07-27 | 2003-02-13 | Hanauske-Abel Hartmut M | Enhancing organ maturity in neonates and predicting their duration of intensive care |
| DK2083863T3 (da) | 2006-10-03 | 2015-06-22 | Genzyme Corp | Antistoffer mod tgf-beta til anvendelse til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi |
| RU2338193C1 (ru) * | 2007-07-18 | 2008-11-10 | Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) | Способ прогнозирования развития ретинопатии недоношенных |
| JP5766947B2 (ja) * | 2007-09-07 | 2015-08-19 | チルドレンズ ホスピタル メディカル センター | 臨床サンプルにおける分泌性のルイス抗原およびシアル化抗原のレベルの疾患リスクの予測指標としての使用 |
| EP2217329B1 (en) * | 2007-11-07 | 2018-01-10 | Anthrogenesis Corporation | Use of umbilical cord blood in the treatment of premature birth complications |
| JP5398054B2 (ja) * | 2008-08-20 | 2014-01-29 | 株式会社 資生堂 | 「シミ」の蓋然性の評価方法 |
| EP2451462B1 (en) | 2009-07-06 | 2017-09-06 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
| RU2445944C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
| RU2445943C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
| RU2445946C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
| RU2445945C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
| US10626460B2 (en) | 2013-02-21 | 2020-04-21 | Children's Hospital Medical Center | Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease |
| RU2526827C1 (ru) * | 2013-05-23 | 2014-08-27 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития пороговой стадии ретинопатии недоношенных у детей без офтальмологических признаков заболевания |
| JP5559406B2 (ja) * | 2013-09-11 | 2014-07-23 | 株式会社 資生堂 | シミを有する蓋然性を評価する方法 |
| RU2536284C1 (ru) * | 2013-09-19 | 2014-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Министерства здравоохранения Российской Федерации" (ГБОУ ВПО РНИМУ Минздрава России) | Способ оценки тяжести течения и возможного исхода ретинопатии у недоношенных детей |
| WO2016176484A1 (en) | 2015-04-28 | 2016-11-03 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| US10392665B2 (en) * | 2015-06-19 | 2019-08-27 | Sera Prognostics, Inc. | Biomarker pairs for predicting preterm birth |
| RU2639134C2 (ru) * | 2016-01-21 | 2017-12-19 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития внутрижелудочковых кровоизлияний у новорожденных, родившихся после экстракорпорального оплодотворения |
| EP4663184A3 (en) * | 2017-09-11 | 2026-03-18 | Oak Hill Bio Limited | Compositions for reducing the incidence of bpd |
| RU2741722C1 (ru) * | 2020-07-06 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования внутрижелудочковых кровоизлияний у недоношенных новорожденных |
| RU2741727C1 (ru) * | 2020-07-06 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития внутрижелудочковых кровоизлияний у недоношенных новорожденных |
| EP3936054A1 (en) * | 2020-07-08 | 2022-01-12 | Assistance Publique - Hôpitaux de Paris | Method of prognosis of bronchopulmonary dysplasia in premature infants |
| CN113528688A (zh) * | 2021-09-09 | 2021-10-22 | 北京泱深生物信息技术有限公司 | 微生物在制备用于诊断生长发育迟缓的产品中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69021335T2 (de) * | 1989-06-09 | 1996-04-11 | Gropep Pty. Ltd., Adelaide | Wachstumshormonfusionsproteine. |
| SE9002731D0 (sv) * | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product comprising growth factor |
| CA2265972A1 (en) * | 1996-09-16 | 1998-03-26 | Philip D. Acott | Use of igf-i for the treatment of polycystic kidney disease and related indications |
| US6121416A (en) * | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| WO2003012043A2 (en) | 2001-07-27 | 2003-02-13 | Hanauske-Abel Hartmut M | Enhancing organ maturity in neonates and predicting their duration of intensive care |
-
2001
- 2001-11-13 DE DE60143858T patent/DE60143858D1/de not_active Expired - Lifetime
- 2001-11-13 CA CA2429615A patent/CA2429615C/en not_active Expired - Lifetime
- 2001-11-13 AU AU2002239560A patent/AU2002239560B2/en not_active Expired
- 2001-11-13 AU AU3956002A patent/AU3956002A/xx active Pending
- 2001-11-13 WO PCT/US2001/047285 patent/WO2002043578A2/en not_active Ceased
- 2001-11-13 AT AT01987331T patent/ATE495443T1/de active
- 2001-11-13 JP JP2002545565A patent/JP4173732B2/ja not_active Expired - Lifetime
- 2001-11-13 EP EP01987331A patent/EP1402266B1/en not_active Expired - Lifetime
-
2003
- 2003-05-28 US US10/446,648 patent/US7144707B2/en not_active Expired - Lifetime
-
2006
- 2006-09-14 US US11/521,209 patent/US7776820B2/en not_active Expired - Lifetime
-
2008
- 2008-03-10 JP JP2008059153A patent/JP5089443B2/ja not_active Expired - Lifetime
-
2011
- 2011-02-22 CY CY20111100212T patent/CY1111213T1/el unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8518877B2 (en) | 2007-04-18 | 2013-08-27 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528529A5 (https=) | ||
| Carbaat et al. | LUMBAR PUNCTURE HEADACHE: CONTROLLED STUDY ON THE PREVENTIVE EFFECT OF 24 HOURS'BED REST | |
| Bittoun | Recurrent aphthous ulcers and nicotine | |
| Angulo et al. | Oral budesonide in the treatment of primary sclerosing cholangitis | |
| TW572756B (en) | Compositions and methods for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation | |
| HUE029397T2 (en) | Selective progesterone modulators for treating uterine bleeding | |
| Van Eygen et al. | Levamisole in prevention of recurrent upper-respiratory-tract infections in children | |
| Choy et al. | A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour | |
| JP2010535805A5 (https=) | ||
| Margolis et al. | Prenatal treatment of X-linked hypohidrotic ectodermal dysplasia using recombinant ectodysplasin in a canine model | |
| JP2023145646A (ja) | 慢性肺疾患を治療するための方法および組成物 | |
| Yoshimatsu et al. | Effects of anti-mouse RANKL antibody on orthodontic tooth movement in mice | |
| Schwab et al. | Kinetics of betamethasone and fetal cardiovascular adverse effects in pregnant sheep after different doses | |
| Salman et al. | Hepatitis B virus infection in pregnant women and transmission to newborns | |
| Cregan et al. | Pre-term delivery and breast expression: consequences for initiating lactation | |
| Juul | Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates | |
| Bialynicki-Birula et al. | Pregnancy-triggered maternal pemphigus vulgaris with persistent gingival lesions | |
| Beltrame et al. | Severe childhood caries associated with iron deficiency anemia: a case report | |
| Åkerlund | Oxytocin antagonists in the treatment of preterm labour | |
| Feurle et al. | The role of CCK and its analogues in the organogenesis of the fetal rat pancreas | |
| Merritt et al. | Epigenetic influences in the development of bronchopulmonary dysplasia | |
| Narayana et al. | Intramuscular oxytocin 10 units versus intravenous methylergometrine 0.2 mg in active management of third stage of labour for prevention of postpartum haemorrhage: a comparative study | |
| JPS60163820A (ja) | 吸引症候群の予防のためのセクレチンおよびこれを含有する薬剤 | |
| Kawahara et al. | Anesthetic management of a patient with Kasabach-Merritt syndrome | |
| Dixon et al. | A novel method for estimating the volume of capillary haemangioma to determine response to treatment. |